The evolving field of biodefence: Therapeutic developments and diagnostics

被引:118
作者
Burnett, JC
Henchal, EA
Schmaljohn, AL
Bavari, S [1 ]
机构
[1] NCI, Dev Therapeut Program, Based Drug Discovery Grp, SAIC, Frederick, MD 21702 USA
[2] USA, Med Res Inst Infect Dis, Frederick, MD 21702 USA
关键词
D O I
10.1038/nrd1694
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The threat of bioterrorism and the potential use of biological weapons against both military and civilian populations has become a major concern for governments around the world. For example, in 2001 anthrax-tainted letters resulted in several deaths, caused widespread public panic and exerted a heavy economic toll. If such a small-scale act of bioterrorism could have such a huge impact, then the effects of a large-scale attack would be catastrophic. This review covers recent progress in developing therapeutic countermeasures against, and diagnostics for, such agents.
引用
收藏
页码:281 / 297
页数:17
相关论文
共 206 条
  • [61] Differentiation of filoviruses by electron microscopy
    Geisbert, TW
    Jahrling, PB
    [J]. VIRUS RESEARCH, 1995, 39 (2-3) : 129 - 150
  • [62] Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: Overexpression of tissue factor in primate monocytes/macrophages is a key event
    Geisbert, TW
    Young, HA
    Jahrling, PB
    Davis, KJ
    Kagan, E
    Hensley, LE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (11) : 1618 - 1629
  • [63] Treatment of Ebola virus infection with a recombinant inhibitor of factor Vila/tissue factor: a study in rhesus monkeys
    Geisbert, TW
    Hensley, LE
    Jahrling, PB
    Larsen, T
    Geisbert, JB
    Paragas, J
    Young, HA
    Fredeking, TM
    Rote, WE
    Vlasuk, GP
    [J]. LANCET, 2003, 362 (9400) : 1953 - 1958
  • [64] A national laboratory network for bioterrorism: Evolution from a prototype network of laboratories performing routine surveillance
    Gilchrist, JR
    [J]. MILITARY MEDICINE, 2000, 165 (07) : 28 - 31
  • [65] GILCHRIST MJR, 2000, LAB SAFETY MANAGEMEN
  • [66] Taking the measure of countermeasures: Leaders' views on the nation's capacity to develop biodefense countermeasures
    Gilfillan, L
    Smith, BT
    Inglesby, TV
    Kodukula, K
    Schuler, A
    Lister, M
    O'Toole, T
    [J]. BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE, 2004, 2 (04) : 320 - 327
  • [67] Goodchild J, 2004, CURR OPIN MOL THER, V6, P119
  • [68] The interferon antiviral response: from viral invasion to evasion
    Grandvaux, N
    tenOever, BR
    Servant, MJ
    Hiscott, J
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2002, 15 (03) : 259 - 267
  • [69] Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents
    Greenfield, RA
    Bronze, MS
    [J]. DRUG DISCOVERY TODAY, 2003, 8 (19) : 881 - 888
  • [70] Comparison of noninvasive sampling sites for early detection of Bacillus anthracis spores from rhesus monkeys after aerosol exposure
    Hail, AS
    Rossi, CA
    Ludwig, GV
    Ivins, BE
    Tammariello, RF
    Henchal, EA
    [J]. MILITARY MEDICINE, 1999, 164 (12) : 833 - 837